查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1428150

综合代谢组 (CMP) 测试 2024 年全球市场报告

Comprehensive Metabolic Panel (CMP) Testing Global Market Report 2024
出版日期: 按订单生产 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

综合代谢组（CMP）测试的市场规模预计在未来几年将显着成长。预计到 2028 年将以 8.3% 的年复合成长率（CAGR）增长至 232.8 亿美元。预测期内的预期增长是由于对个人化医疗和精准医疗保健的日益重视、综合代谢组 (CMP) 测试与远端医疗服务的整合、对综合健康检查、保健和预防性健康的需求不断增长而推动的。这可能是由于更加关注医疗保健以及医疗保健政策和监管的持续发展。在此期间预计的主要趋势包括对健康参数的持续监测和长期跟踪、与远端医疗兼容的报告格式、提高可比性的参考范围标准化以及资料（包括集成可穿戴医疗技术以收集、医疗保健生态系统以加强病患教育）和参与。

心血管疾病和糖尿病盛行率的预期增加预计将推动综合代谢组（CMP）测试市场的成长。影响心臟和血管的心血管疾病通常与动脉粥状硬化（动脉内脂肪沉积物的堆积）有关。同时，以血糖值升高为特征的糖尿病可以透过综合代谢组（CMP）血液检查来识别。随着糖尿病和心血管疾病病例的增加，对诊断性血液检测（包括 CMP 血液检测）的需求可能会激增。例如，澳洲健康与福利研究所提供的2023年12月资料显示，医生归因于心臟疾病（CHD）的死亡人数呈上升趋势，2022年将达到14,900人。此外，2022 年 6 月，国际糖尿病联盟报告称，全球糖尿病盛行率为 10.5%，其中很大一部分（44.7%）仍未确诊。因此，心血管疾病和糖尿病发生率的增加是推动综合代谢组（CMP）测试市场的主要驱动力。

预计老年人口的增加将在不久的将来显着促进综合代谢组（CMP）检测市场的扩大。 「老年人口」一词是指年龄在65岁及以上的人，他们需要更频繁地进行健康检查，以监测自己的健康状况并解决与老龄化相关的健康问题。代谢组测试在这一人群中变得极为重要，可以作为检测老年人肾臟疾病、荷尔蒙失衡和糖尿病等潜在疾病的工具。 2022年11月，美国健康排名报告称，2021年美国65岁及以上人口预计将超过5,580万，约占总人口的16.8%。随着这一人群的持续增长，对综合代谢组合（CMP）测试的需求预计将会增加，其中老年人口是综合代谢组合（CMP）测试市场的主要驱动力。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球综合代谢组 (CMP) 测试市场驱动因素与阻碍因素
    • 市场驱动力
    • 市场限制
  • 全球综合代谢组 (CMP) 测试市场规模、表现和成长，2018-2023 年
  • 全球综合代谢组 (CMP) 测试市场规模与成长预测，2023-2028 年、2033 年

第六章市场区隔

  • 全球综合代谢组 (CMP) 测试市场，按疾病、表现和预测细分，2018-2023、2023-2028、2033
  • 肾臟疾病
  • 肝病
  • 糖尿病
  • 其他疾病
  • 全球综合代谢组 (CMP) 测试市场，按测试类型、性能和预测细分，2018-2023、2023-2028、2033
  • 蛋白质
  • 电解质
  • 肾臟测试
  • 肝功能检查
  • 葡萄糖
  • 全球综合代谢组 (CMP) 测试市场，按最终用户细分、性能和预测，2018-2023、2023-2028、2033
  • 实验室
  • 照护现场(PoC)

第 7 章 区域与国家分析

  • 全球综合代谢组 (CMP) 测试市场，按地区、实际和预测，2018-2023、2023-2028、2033
  • 全球综合代谢组 (CMP) 测试市场，按国家、实际和预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争形势及公司概况

  • 综合代谢组（CMP）检测市场竞争形势
  • 综合代谢组（CMP）测试市场公司概况
    • F Hoffmann-La Roche Ltd.
    • Abbott Laboratories Inc.
    • Siemens Healthineers AG
    • Mayo Clinic
    • Laboratory Corporation of America Holdings

第31章 其他大型创新公司

  • Mercy
  • Mount Sinai Health System
  • Quest Diagnostics Incorporated
  • Sonic Healthcare Limited
  • Hologic Inc.
  • Beckman Coulter Inc.
  • Bio-Rad Laboratories Inc.
  • Werfen SA
  • DiaSorin SpA
  • Randox Laboratories Ltd.
  • ARUP Laboratories Inc.
  • Invitae Corporation
  • Abaxis Inc.
  • Metropolis Healthcare Limited
  • Clinical Reference Laboratory（CRL）

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来前景与可能性分析

第36章附录

简介目录
Product Code: r13994

A comprehensive metabolic panel (CMP) test is a blood analysis consisting of 14 distinct parameters that provide crucial insights into the body's chemical balance and metabolic processes. This test serves as a vital tool for evaluating nutritional levels, liver and kidney functionality, and aids in diagnosing, screening, and monitoring various health conditions.

The primary diseases and health conditions assessed through comprehensive metabolic panel (CMP) testing include kidney disease, liver disease, diabetes, and other metabolic disorders. Kidney disease is characterized by impaired kidney function, affecting its ability to effectively filter blood and perform essential functions. The test encompasses evaluations of proteins, electrolytes, kidney function, liver function, and glucose levels, conducted in both laboratory settings and point-of-care (PoC) environments.

The comprehensive metabolic panel (CMP) testing market research report is one of a series of new reports from The Business Research Company that provides comprehensive metabolic panel (CMP) testing market statistics, including comprehensive metabolic panel (CMP) testing industry global market size, regional shares, competitors with a comprehensive metabolic panel (CMP) testing market share, detailed comprehensive metabolic panel (CMP) testing market segments, market trends and opportunities, and any further data you may need to thrive in the comprehensive metabolic panel (CMP) testing industry. This comprehensive metabolic panel (CMP) testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The comprehensive metabolic panel (cmp) testing market size has grown strongly in recent years. It will grow from $15.61 billion in 2023 to $16.94 billion in 2024 at a compound annual growth rate (CAGR) of 8.5%. The growth observed in the historic period can be attributed to several factors, including an increase in chronic diseases, a growing demand for comprehensive health assessments, a shift within healthcare systems towards preventive care, a rise in conditions related to lifestyle factors, and an emphasis on patient-centric healthcare approaches. These factors collectively contributed to the expansion and evolution of healthcare services and practices during that period.

The comprehensive metabolic panel (cmp) testing market size is expected to see strong growth in the next few years. It will grow to $23.28 billion in 2028 at a compound annual growth rate (CAGR) of 8.3%. The anticipated growth in the forecast period can be attributed to several factors, including the increasing emphasis on personalized medicine and precision healthcare, the integration of Comprehensive Metabolic Panel (CMP) testing within telehealth services, a growing demand for comprehensive health screenings, an upsurge in wellness and preventive health initiatives, and ongoing evolution in healthcare policies and regulations. Major trends expected in this period encompass continuous monitoring and longitudinal tracking of health parameters, reporting formats tailored for telemedicine compatibility, standardization of reference ranges for better comparability, integration of wearable health technology for data collection, and a heightened focus on patient education and engagement within the healthcare ecosystem.

The anticipated rise in the prevalence of cardiovascular diseases and diabetes is expected to be a driving force behind the growth of the comprehensive metabolic panel (CMP) testing market. Cardiovascular diseases, which affect the heart and blood vessels, are often associated with atherosclerosis-the accumulation of fatty deposits within arteries. Concurrently, diabetes, characterized by elevated blood glucose levels, can be identified through comprehensive metabolic panel (CMP) blood tests. As cases of diabetes and cardiovascular diseases increase, the demand for diagnostic blood tests, including the CMP blood test, is likely to surge. For instance, data from December 2023 provided by the Australian Institute of Health and Welfare indicated a rising trend in doctor-certified fatalities attributed to coronary heart disease (CHD), reaching 14,900 in 2022. Additionally, in June 2022, the International Diabetes Federation reported a global diabetes prevalence of 10.5%, with a significant portion (44.7%) of individuals remaining undiagnosed. Consequently, the growing incidence of cardiovascular diseases and diabetes is a key driver propelling the comprehensive metabolic panel (CMP) testing market.

The increasing geriatric population is anticipated to contribute significantly to the expansion of the comprehensive metabolic panel (CMP) testing market in the foreseeable future. The term 'geriatric population' refers to individuals who are elderly, typically aged 65 or older, requiring more frequent health tests to monitor their well-being and address age-related health issues. Metabolic panel testing becomes crucial in this demographic, serving as a tool to detect underlying conditions such as kidney diseases, hormonal imbalances, and diabetes in older adults. In November 2022, America's Health Rankings reported that the United States is projected to have more than 55.8 million individuals aged 65 and above in 2021, accounting for approximately 16.8% of the total population. As this demographic continues to grow, the demand for comprehensive metabolic panel (CMP) testing is expected to rise, making the geriatric population a key driver in the comprehensive metabolic panel (CMP) testing market.

The comprehensive metabolic panel (CMP) testing market is witnessing a significant trend of technological advancements, with major companies investing in innovative solutions to fortify their market positions. In April 2022, HealthifyMe, an Indian wellness and fitness services company, introduced HealthifyPro, a flagship fitness plan incorporating a metabolic panel based on a comprehensive blood test measuring over 80 different factors. HealthifyPro utilizes a biosensor system, a smart scale, health coaches, an AI assistant, and a metabolic panel to track users' health. The integration of glucose patterns, dietary habits, and exercise behaviors enables the creation of personalized health approaches for each user, showcasing the role of technology in advancing metabolic panel testing.

Strategic partnerships are a prominent approach adopted by major companies in the comprehensive metabolic panel (CMP) testing market. These partnerships aim to enhance production capabilities, streamline testing processes, and meet the increasing demand for CMP testing across various industries. In August 2022, Abbott Laboratories, a US-based healthcare company, collaborated with WW International Inc., a provider of weight loss and fitness services. The partnership focuses on assisting individuals with diabetes in better understanding and managing their health. By integrating WeightWatchers' diabetes-specific weight management program with Abbott's FreeStyle Libre offerings, the collaboration aims to provide a seamless mobile experience, offering valuable insights for individuals with diabetes to make informed dietary adjustments and improve blood sugar levels, ultimately empowering them to take control of their health.

In March 2023, Fluxery, a medical diagnostic company headquartered in the United States, completed the acquisition of particular personnel, assets, and licensed electrochemical biosensing technologies from InnaMed Inc. The financial details of the transaction remain undisclosed. This strategic acquisition by Fluxery significantly expands its detection capabilities, allowing for the analysis of clinical chemistry and small molecules in various domains, including human healthcare, equine care, and veterinary services for small animals. InnaMed Inc., a decentralized blood testing company in the US, specializes in electrochemical biosensor technology.

Major companies operating in the comprehensive metabolic panel (cmp) testing market report are F Hoffmann-La Roche Ltd., Abbott Laboratories Inc., Siemens Healthineers AG, Mayo Clinic, Laboratory Corporation of America Holdings, Mercy, Mount Sinai Health System, Quest Diagnostics Incorporated, Sonic Healthcare Limited, Hologic Inc., Beckman Coulter Inc., Bio-Rad Laboratories Inc., Werfen SA, DiaSorin S.p.A., Randox Laboratories Ltd., ARUP Laboratories Inc., Invitae Corporation, Abaxis Inc., Metropolis Healthcare Limited, Clinical Reference Laboratory (CRL), Centogene AG, Spectra Laboratories, Unipath Systems Ltd., Scion Lab Services LLC, Weldon Biotech Pvt Ltd., Corona Pathology,Ulta Lab Tests LLC, Any Lab Test Now, Applied InGENuity Diagnostics LLC, Walk-In Lab LLC.

North America was the largest region in the comprehensive metabolic panel (CMP) testing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the comprehensive metabolic panel (cmp) testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the comprehensive metabolic panel (cmp) testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The comprehensive metabolic panel (CMP) testing market includes revenues earned by entities by providing glucose tests, sodium tests, and albumin tests. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Comprehensive Metabolic Panel (CMP) Testing Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on comprehensive metabolic panel (cmp) testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for comprehensive metabolic panel (cmp) testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The comprehensive metabolic panel (cmp) testing market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Disease: Kidney Disease; Liver Disease; Diabetes; Other Diseases
  • 2) By Test Type: Proteins; Electrolytes; Kidney Tests; Liver Functional Tests; Glucose
  • 3) By End User: Laboratories; Point Of Care (PoC)
  • Companies Mentioned: F Hoffmann-La Roche Ltd.; Abbott Laboratories Inc.; Siemens Healthineers AG; Mayo Clinic; Laboratory Corporation of America Holdings
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Comprehensive Metabolic Panel (CMP) Testing Market Characteristics

3. Comprehensive Metabolic Panel (CMP) Testing Market Trends And Strategies

4. Comprehensive Metabolic Panel (CMP) Testing Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Comprehensive Metabolic Panel (CMP) Testing Market Size and Growth

  • 5.1. Global Comprehensive Metabolic Panel (CMP) Testing Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Comprehensive Metabolic Panel (CMP) Testing Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Comprehensive Metabolic Panel (CMP) Testing Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Comprehensive Metabolic Panel (CMP) Testing Market Segmentation

  • 6.1. Global Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Kidney Disease
  • Liver Disease
  • Diabetes
  • Other Diseases
  • 6.2. Global Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Proteins
  • Electrolytes
  • Kidney Tests
  • Liver Functional Tests
  • Glucose
  • 6.3. Global Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Laboratories
  • Point Of Care (PoC)

7. Comprehensive Metabolic Panel (CMP) Testing Market Regional And Country Analysis

  • 7.1. Global Comprehensive Metabolic Panel (CMP) Testing Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Comprehensive Metabolic Panel (CMP) Testing Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Comprehensive Metabolic Panel (CMP) Testing Market

  • 8.1. Asia-Pacific Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Comprehensive Metabolic Panel (CMP) Testing Market

  • 9.1. China Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • 9.2. China Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Comprehensive Metabolic Panel (CMP) Testing Market

  • 10.1. India Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Comprehensive Metabolic Panel (CMP) Testing Market

  • 11.1. Japan Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • 11.2. Japan Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Comprehensive Metabolic Panel (CMP) Testing Market

  • 12.1. Australia Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Comprehensive Metabolic Panel (CMP) Testing Market

  • 13.1. Indonesia Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Comprehensive Metabolic Panel (CMP) Testing Market

  • 14.1. South Korea Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • 14.2. South Korea Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Comprehensive Metabolic Panel (CMP) Testing Market

  • 15.1. Western Europe Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • 15.2. Western Europe Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Comprehensive Metabolic Panel (CMP) Testing Market

  • 16.1. UK Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Comprehensive Metabolic Panel (CMP) Testing Market

  • 17.1. Germany Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Comprehensive Metabolic Panel (CMP) Testing Market

  • 18.1. France Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Comprehensive Metabolic Panel (CMP) Testing Market

  • 19.1. Italy Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Comprehensive Metabolic Panel (CMP) Testing Market

  • 20.1. Spain Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Comprehensive Metabolic Panel (CMP) Testing Market

  • 21.1. Eastern Europe Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • 21.2. Eastern Europe Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Comprehensive Metabolic Panel (CMP) Testing Market

  • 22.1. Russia Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Comprehensive Metabolic Panel (CMP) Testing Market

  • 23.1. North America Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • 23.2. North America Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Comprehensive Metabolic Panel (CMP) Testing Market

  • 24.1. USA Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • 24.2. USA Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Comprehensive Metabolic Panel (CMP) Testing Market

  • 25.1. Canada Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • 25.2. Canada Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Comprehensive Metabolic Panel (CMP) Testing Market

  • 26.1. South America Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • 26.2. South America Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Comprehensive Metabolic Panel (CMP) Testing Market

  • 27.1. Brazil Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Comprehensive Metabolic Panel (CMP) Testing Market

  • 28.1. Middle East Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • 28.2. Middle East Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Comprehensive Metabolic Panel (CMP) Testing Market

  • 29.1. Africa Comprehensive Metabolic Panel (CMP) Testing Market Overview
  • 29.2. Africa Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Disease, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By Test Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Comprehensive Metabolic Panel (CMP) Testing Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Comprehensive Metabolic Panel (CMP) Testing Market Competitive Landscape And Company Profiles

  • 30.1. Comprehensive Metabolic Panel (CMP) Testing Market Competitive Landscape
  • 30.2. Comprehensive Metabolic Panel (CMP) Testing Market Company Profiles
    • 30.2.1. F Hoffmann-La Roche Ltd.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Abbott Laboratories Inc.
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Siemens Healthineers AG
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Mayo Clinic
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Laboratory Corporation of America Holdings
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Comprehensive Metabolic Panel (CMP) Testing Market Other Major And Innovative Companies

  • 31.1. Mercy
  • 31.2. Mount Sinai Health System
  • 31.3. Quest Diagnostics Incorporated
  • 31.4. Sonic Healthcare Limited
  • 31.5. Hologic Inc.
  • 31.6. Beckman Coulter Inc.
  • 31.7. Bio-Rad Laboratories Inc.
  • 31.8. Werfen SA
  • 31.9. DiaSorin S.p.A.
  • 31.10. Randox Laboratories Ltd.
  • 31.11. ARUP Laboratories Inc.
  • 31.12. Invitae Corporation
  • 31.13. Abaxis Inc.
  • 31.14. Metropolis Healthcare Limited
  • 31.15. Clinical Reference Laboratory (CRL)

32. Global Comprehensive Metabolic Panel (CMP) Testing Market Competitive Benchmarking

33. Global Comprehensive Metabolic Panel (CMP) Testing Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Comprehensive Metabolic Panel (CMP) Testing Market

35. Comprehensive Metabolic Panel (CMP) Testing Market Future Outlook and Potential Analysis

  • 35.1 Comprehensive Metabolic Panel (CMP) Testing Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Comprehensive Metabolic Panel (CMP) Testing Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Comprehensive Metabolic Panel (CMP) Testing Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer